Page last updated: 2024-10-20

propionic acid and Cardiac Hypertrophy

propionic acid has been researched along with Cardiac Hypertrophy in 1 studies

propionic acid : A short-chain saturated fatty acid comprising ethane attached to the carbon of a carboxy group.

Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.

Research Excerpts

ExcerptRelevanceReference
" Susceptibility to cardiac ventricular arrhythmias was significantly reduced in propionate-treated angiotensin II-infused wild-type NMRI mice."3.91Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage. ( Avery, EG; Balogh, A; Bartolomaeus, H; Dechend, R; Eckardt, KU; Fielitz, J; Forslund, SK; Gollasch, M; Grandoch, M; Haase, N; Hering, L; Höges, S; Homann, S; Kempa, S; Kozhakhmetov, S; Kräker, K; Krannich, A; Kusche-Vihrog, K; Kushugulova, A; Maase, M; Markó, L; Müller, DN; Rump, LC; Stegbauer, J; Tsvetkov, D; Wilck, N; Wundersitz, S; Yakoub, M; Zhumadilov, Z, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartolomaeus, H1
Balogh, A1
Yakoub, M1
Homann, S1
Markó, L1
Höges, S1
Tsvetkov, D1
Krannich, A1
Wundersitz, S1
Avery, EG1
Haase, N1
Kräker, K1
Hering, L1
Maase, M1
Kusche-Vihrog, K1
Grandoch, M1
Fielitz, J1
Kempa, S1
Gollasch, M1
Zhumadilov, Z1
Kozhakhmetov, S1
Kushugulova, A1
Eckardt, KU1
Dechend, R1
Rump, LC1
Forslund, SK1
Müller, DN1
Stegbauer, J1
Wilck, N1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Mechanisms Linking Dietary Fiber, the Microbiome and Satiety[NCT04611217]88 participants (Anticipated)Interventional2021-04-22Recruiting
Prebiotic Therapy to Improve Outcomes of Renal Transplant[NCT04428190]Early Phase 160 participants (Anticipated)Interventional2022-02-23Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for propionic acid and Cardiac Hypertrophy

ArticleYear
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage.
    Circulation, 2019, 03-12, Volume: 139, Issue:11

    Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Diseases; Arrhythmias, Cardiac; Arterial P

2019
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage.
    Circulation, 2019, 03-12, Volume: 139, Issue:11

    Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Diseases; Arrhythmias, Cardiac; Arterial P

2019
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage.
    Circulation, 2019, 03-12, Volume: 139, Issue:11

    Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Diseases; Arrhythmias, Cardiac; Arterial P

2019
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage.
    Circulation, 2019, 03-12, Volume: 139, Issue:11

    Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Diseases; Arrhythmias, Cardiac; Arterial P

2019